New Hope for Targeting the Spike Protein: A Potential Threat
A team of Italian scientists have achieved a significant breakthrough, offering renewed hope to millions suffering from a wide array of health consequences of the spike protein including Long COVID and post-CoVID-19 vaccine syndrome, also referred to as Long VAX. They tested a number of natural supplements to determine if they could clear persistent spike protein in the body and discovered that NAC (N-acetylcysteine) was the most active. NAC is naturally produced in the body and is an essential precursor to glutathione—the body’s master antioxidant—known for its wide-ranging health benefits. By employing advancements in quantum biophysics, they modified the molecular configuration of NAC to dramatically enhance this effect in clearing the spike protein. This and other actions of Augmented NAC are outlined in more detail below. Very importantly, the promising lab results have translated into clinical improvements in thousands of individuals, based on physician and patient reports.
What is the Spike Protein?
The spike protein on the surface of the COVID-19 virus, enables the virus to enter human cells. It is therefore the primary target for vaccines designed to prevent COVID-19 infection.
CoVID-19 vaccines
The goal of vaccination is to train the immune system to recognize and neutralize the spike protein, thereby mounting a rapid response upon future exposure to the virus. Several spike based vaccine platforms have been developed as illustrated below:
Why is it Important to Clear Persistent Spike Protein from the Body?
Extensive research has shown that the spike protein can exert toxic effects on various cells and organs. Click here for an extensive list of publications documenting these effects, which may depend on:
• Which tissues are exposed
• How much spike protein is produced
• How long the spike protein persists
These effects can occur even in the absence of the whole CoVID-19 virus and a small number of the many recognized harmful biological effects of the spike protein are illustrated below:
Who is at risk?
In individuals who efficiently clear the virus, the effects of COVID-19 may be limited. However, in some cases, the spike protein persists in the body, potentially leading to serious health consequences.
When it comes to vaccination, gene-based platforms pose unique concerns regarding spike protein exposure.
These vaccines use DNA or RNA to deliver genetic instructions that, like the virus itself, hijack the cell’s machinery to produce the spike protein. Once produced, this foreign protein is displayed on the surface of the cell—marking it as a target for destruction. This may be especially problematic in organs with lower potential for tissue regeneration like the heart or brain.
The Covid-19 virus DNA vector vaccines and mRNA vaccines use the cells machinery to make spike protein which is displayed on the surface of the cells.
This approach poses distinct challenges as there is no control over the:
DOSE: how much spike protein is produced by each individual
DURATION: there is no built-in mechanism to turn off spike production once it begins
DISTRIBUTION: Although initial assurances indicated the vaccine would remain localized at the injection site, there is now strong evidence that the lipid nanoparticles and encoded genetic instructions distribute throughout the body, reaching organs such as the heart, liver, brain, reproductive tissues and elsewhere.
Long COVID and Long VAX
Published data indicates that persons with Long COVID were twice as likely to have persistent spike protein in their blood as those with no lingering symptoms. Spike protein has been detected up to 15 months after infection in these cases.
A recent publication also documented persistent spike protein more than 700 days after vaccination in persons with Long VAX, even those with no evidence of CoVID-19 infection. Another team of researchers tested up to 245 days post-vaccination and confirmed the presence of vaccine derived spike protein in 92% of the long VAX cases. It appears that some individuals may be more susceptible to these issues, particularly those with:
Certain genetic traits
A pre-existing overactive or dysregulated immune system
A high or widely distributed exposure to the spike protein (e.g., from disseminated mRNA lipid nano particles)
Ongoing exposure to spike protein could continue to activate the immune system, fueling chronic inflammation and tissue dysfunction. There is a significant symptom overlap between long COVID and long VAX, which is not surprising as persistent spike protein appears to play a causative role in both conditions. A few of the common findings and how they arise are illustrated below:
Other Health Issues
Ongoing exposure to the spike protein may contribute to a wide range of health conditions. Because many of these conditions are common and may have a delayed onset, a link to spike protein exposure is often missed.
However, large population studies have now identified a significant rise in cardiovascular and other health issues among individuals who received COVID-19 vaccines.
A meta-analysis involving 85 million people in a number of countries reported a significant increase in the rate of coronary heart disease, heart attacks, irregular heart rhythms and strokes:
These figures suggest a doubling in the rates of potentially serious medical conditions. Considering that cardiovascular disease was already a leading contributor to the chronic disease burden, this data is cause for concern.
Notable increases in less serious conditions have also been documented following both COVID-19 infection and vaccination. The medical community has readily recognized the many damaging effects of CoVID-19 infection but have been very slow to acknowledge those which may occur after vaccination.
A large Korean study of nearly 2 million individuals found increases in visual impairment, shingles, warts, hair loss, menstrual disorders and other common conditions among vaccinated individuals compared to the unvaccinated:
Augmented NAC
Given the potentially serious and wide-ranging harms associated with significant or ongoing exposure to the spike protein, it is essential to find effective strategies to neutralize its impact—or better yet, eliminate it from the body altogether.
In this context, Augmented NAC may provide a potential solution—addressing the root cause of spike-related health issues while also mitigating some of its most critical downstream effects.
Fortunately, other helpful strategies have also been proposed. A number of these interventions have been found to be helpful in reducing the stubborn and sometimes debilitating symptoms encountered in this context. Support for these measures is based mainly on anecdotal experience - but clinical responses have been very encouraging so far.
Is it safe?
NAC is a well-established compound produced naturally by our cells and has been used for decades in both hospital and community settings—most notably to treat liver toxicity from acetaminophen overdose, support recovery from respiratory infections, and enhance antioxidant capacity. It has a long record of safe use and provides numerous benefits beyond it’s potential for spike detox, resulting in a highly favorable risk–benefit profile.
A Powerful Spike Detox
Several drugs and supplements have been recommended to block certain actions of the spike protein. However, the discovery that NAC not only blocks, but also denatures (destroys) 12 to 20% of the spike protein is particularly significant. On the other hand, Augmented NAC achieved a staggering 99.8% denaturation based on laboratory tests—a finding which appears to offer enormous potential for those affected by spike-related conditions.
Breakdown of Stubborn Clots
It is now recognized that microclots—triggered by the spike protein—are a major contributor to the lung damage seen in acute COVID-19. These microclots are also a defining feature of both long COVID and long VAX, with the spike protein again implicated as a key driver. By impairing blood flow to vital organs, they are thought to contribute to symptoms such as fatigue, shortness of breath, and other signs of poor oxygen delivery. This may help explain the broad range of symptoms seen in these sometimes debilitating syndromes.
Because microclots are typically invisible on standard scans, patients may experience notable symptoms but may have normal test results. In more severe cases, larger clots can form, causing acute events such as strokes, heart attacks, visual impairment or limb ischemia—sometimes requiring surgical intervention or even amputation.
Importantly, spike-induced clots differ from conventional thrombi and are often resistant to standard treatments. This makes the finding that Augmented NAC may not only slowly eliminate the spike protein but may also have the capacity to dissolve a substantial proportion of these clots particularly significant.
In practice Augmented NAC is often combined with other measures which have shown promise in addressing spike-related micro-clots.
Antioxidant Boost
Runaway inflammation and oxidative stress are key drivers of tissue and organ damage in long COVID, long VAX and other spike-related conditions. NAC plays a multi-faceted role in countering these effects. As noted earlier, it directly destroys the spike protein—a critical upstream trigger. In addition, NAC helps reduce inflammation and enhance antioxidant defenses through several mechanisms:
It serves as a vital precursor to glutathione, an antioxidant which plays a major role in the body.
It protects and preserves the function of glutathione and other antioxidants, such as vitamin C, enhancing their effectiveness.
It also has its own intrinsic anti-inflammatory and antioxidant properties.
Augmented NAC performs all of these functions to a significantly enhanced degree compared to standard NAC:
Clinical ResPonse
The remarkable clinical improvement reported by hundreds of individuals worldwide who opted to take Augmented NAC may be even more compelling than the laboratory findings.
Dr. Tina Peers, a UK physician in practice for over 40 years, shared her personal experience following her second COVID-19 vaccine dose. She developed burning mouth syndrome, persistent eczema, rosacea, recurrent episodes of peripheral epilepsy, and a tremor in her right hand that developed within hours of the injection, and lasted for two years. She reports that within 24 to 48 hours of starting Augmented NAC, the tremor resolved and has not returned. As she continued supplementation, all remaining symptoms gradually cleared. However it is important to note that she had already commenced other health strategies prior to taking Augmented NAC, which may have set the stage for her dramatic recovery.
Click on the image below to view additional amazing testimonials.
It is important to note that although these dramatic responses have been observed in many cases, it is far from universal. As these are complex, multifactorial conditions, Augmented NAC often needs to be paired with other health strategies for maximal response.
Is this relevant for me?
If you have noted stubborn and unusual new symptoms or a marked escalation of prior symptoms within recent years, it is worth considering if this may be a factor. Direct tests for persistent spike protein are available on a research basis and in Europe. However there are very helpful surrogate tests which are widely available that can provide a useful indicator.
Next Steps
If you are interested in accessing our long COVID and long VAX strategies including Augmented NAC, or other supportive measures including zeolite, nattokinase, methylene blue or pure far infrared therapy, complete the confidential health screening questionnaire below or Contact Us at Luminnova Health.